Class I Recall

Jacobus Pharmaceutical Company Inc.

Product
Ruzurgi (amifampridine) Tablets 10 mg, packaged in 100-count bottles, Rx only, Manufactured by: Jacobus Pharmaceutical Company, Inc, P.O. Box 5290, Princeton, New Jersey 08540, NDC 49938-110-01.
Reason
Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.
Classification
Class I
Status
Terminated
Lot
Lot #: 18038, 18039, Exp 03/2023; 18079, Exp 05/2023
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Jacobus Pharmaceutical Company Inc. — Class I Recall | MedicineWatch US